Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway-Reference-Cited by-同舟云学术

Rosuvastatin Attenuates CD40L-Induced Downregulation of Extracellular Matrix Production in Human Aortic Smooth Muscle Cells via TRAF6-JNK-NF-κB Pathway

Published:2016-04-27 Issue:4 Volume:11 Page:e0153919
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Wang Xiao-Lin,Zhou Yuan-Li,Sun Wei,Li Li

Funder

the National Natural Science Funds for Young Scholar

the Key R & D program in Shandong Province

grants from the Shandong Young Scientists Award Fund

grants from Scientific and Technology Development program of Jinan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. Coronary plaque disruption;E Falk;Circulation,1995

2. Mechanisms of plaque vulnerability and rupture;P K Shah;J Am Coll Cardiol,2003

3. Molecular bases of the acute coronary syndromes;P Libby;Circulation,1995

4. Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases;K I Kivirikko;Adv Enzymol Relat Areas Mol Biol,1997

5. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques;ZS Galis;J Clin Invest,1994

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipotoxicity, glucotoxicity and some strategies to protect vascular smooth muscle cell against proliferative phenotype in metabolic syndrome;Food and Chemical Toxicology;2023-02

2. Rhamnan sulfate reduces atherosclerotic plaque formation and vascular inflammation;Biomaterials;2022-12

3. NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy;International Immunopharmacology;2019-08

4. Rosuvastatin stabilizes atherosclerotic plaques by reducing CD40L overexpression-induced downregulation of P4Hα1 in ApoE−/− mice;The International Journal of Biochemistry & Cell Biology;2018-12

5. Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all;Translational Research;2018-05